More molecules for tuberculosis

Mar 11, 2011

Scientists are collaborating on a new international research project to identify antibiotics that can kill tuberculosis and fight resistant strains.

"We want to accelerate the discovery of new compounds that can be turned into effective drugs," said Professor Tony Maxwell from the John Innes Centre, a key player in "More Medicines for Tuberculosis", a new European research project.

Two billion people are currently infected with TB and three million die every year. TB causes more deaths than any other infectious disease. Rates are increasing, especially in sub-Saharan Africa, where people with HIV are particularly vulnerable. It is also associated with intravenous drug use and increased rates may be linked to immigration.

"The is difficult to get at," said Professor Maxwell. "It is slow growing, spends a lot of time hidden in cells before it makes itself known, and has very tough cell walls of its own."

Treatment is relatively long term, requiring a drug regime over four to six months. Non-compliance is a problem, exacerbating the challenge caused by .

"Drug discovery research for tuberculosis is dependent on academic labs and no single lab can do it", said Professor Maxwell.

Scientists from 25 labs across Europe will collaborate on the new project including some groups in the US and India.

The John Innes Centre scientists will focus on compounds that target DNA gyrase, a target that they have already established as effective and safe. They will receive compounds from European collaborators including . They will screen those that knock out DNA gyrase. Their research will continue on those compounds that are effective both against the target (DNA gyrase) and the bacterium.

Working on new compounds to hit known targets, rather than compounds that may struggle to access or that may have unknown effects in humans, will provide a quicker route to clinical trials.

"Finding new that work is only the first step," warns Professor Maxwell.

The next stage will be to determine how exactly the antibiotic compound operates and whether it has a hope of working in a clinical environment.

One group of compounds under study at JIC are naphthoquinones, originally extracted from plants including the toothbrush tree, Euclea natalensis.

Explore further: Saudi reports new MERS death, infections in Jeddah

Provided by Norwich BioScience Institutes

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Energy-saving bacteria resist antibiotics

Sep 03, 2008

Bacteria save energy by producing proteins that moonlight, having different roles at different times, which may also protect the microbes from being killed. The moonlighting activity of one enzyme from the tuberculosis bacterium ...

Cancer drug target is promising lead for new TB treatments

Nov 17, 2010

A key enzyme in Mycobacterium tuberculosis that enables the microbe to reproduce rapidly could be a golden target for new drugs against tuberculosis (TB), according to a study published in Microbiology on 17 November. ...

Engineered bacterium churns out two new key antibiotics

Feb 18, 2009

(PhysOrg.com) -- In recent years, scientists have isolated two potent natural antibiotics — platensimycin and platencin — that are highly effective against bacterial infection, including those caused by the most dreaded ...

New chemical can kill latent tuberculosis bacteria

Mar 14, 2008

Success in the laboratory suggests that a new compound can point the way to preventing active tuberculosis in people infected with the latent form of the bacterium, says a team led by researchers at Weill Cornell Medical ...

Recommended for you

Thyroid disease risk varies among blacks, Asians, and whites

15 hours ago

An analysis that included active military personnel finds that the rate of the thyroid disorder Graves disease is more common among blacks and Asian/Pacific Islanders compared with whites, according to a study in the April ...

The key to easy asthma diagnosis is in the blood

17 hours ago

Using just a single drop of blood, a team of University of Wisconsin-Madison researchers has developed a faster, cheaper and more accurate tool for diagnosing even mild cases of asthma.

User comments : 0

More news stories

ESO image: A study in scarlet

This new image from ESO's La Silla Observatory in Chile reveals a cloud of hydrogen called Gum 41. In the middle of this little-known nebula, brilliant hot young stars are giving off energetic radiation that ...

First direct observations of excitons in motion achieved

A quasiparticle called an exciton—responsible for the transfer of energy within devices such as solar cells, LEDs, and semiconductor circuits—has been understood theoretically for decades. But exciton movement within ...

Patent talk: Google sharpens contact lens vision

(Phys.org) —A report from Patent Bolt brings us one step closer to what Google may have in mind in developing smart contact lenses. According to the discussion Google is interested in the concept of contact ...

Warm US West, cold East: A 4,000-year pattern

Last winter's curvy jet stream pattern brought mild temperatures to western North America and harsh cold to the East. A University of Utah-led study shows that pattern became more pronounced 4,000 years ago, ...